Font Size: a A A
Keyword [First part]
Result: 1 - 15 | Page: 1 of 1
1. The First Part Association Analysis Of The ~G-γ Hemoglobin Gene Promoter -158C/T Polymorphism With Hemoglobin E/β-Thalassemia Major
2. The First Part Of The Screening Of Anti-TB Drugs For Shikimate Dehydrogenase As A Target For Preliminary Studies Of Mycobacterium Tuberculosis Acid Mechanisms Of Drug Screening Model Targeting The Second Part
3. The First Part TOSO By Activating SYK Promote Chronic Lymphocytic Leukemia Cell Survival Mechanism Of Action 60 Years Old Adult Ph / BCR-ABL-positive Acute Lymphoblastic Leukemia Effect Analysis Part II - Single-center Clinical Study BDH ALL 2000/02 Progr
4. The First Part Of PHLDA3 Gene Inactivation Leads To Tumorigenesis And Clinical Significance. The Second Part Of The Pancreatic Neuroendocrine Tumor YY1 Gene Hotspot Mutation
5. The First Part: Correlation Of Sperm Parameters With Pregnancy Rate Undergoing Intrauterine Insemination
6. The First Part Of The Prognostic Significance Of DAXX Gene Mutation In Pancreatic Neuroendocrine Tumors The Second Part Of Pancreatic Neuroendocrine Tumors In The Expression Of MAP2, MAP1B And Its Prognostic Significance
7. The First Part Of Interferon α-1a Induces Apoptosis Of Laryngeal Carcinoma Hep-2 Cells By Activating Endogenous Mitochondrial Apoptosis Pathway And Endoplasmic Reticulum Stress Apoptotic Pathway. The Second Part Of Microfluidic Western Blot Hybridization
8. The First Part Of The ZP4 Gene Single Nucleotide Polymorphism And The Chinese Han Population With Primary Open Angle Glaucoma. The Second Part Of A Genetic Stress Susceptibility Peripheral Neuropathy Family Candidate Gene PMP22 Screening Study
9. The First Part Is The Study Of The Specific Changes And Mechanism Of The Bone Marrow Hematopoietic Microenvironment In Patients With Essential Thrombocythemia. The Second Part Is The Evaluation Of The Symptom Burden Of 173 Chinese Patients With Essential
10. The First Part Is A Clinical Study Of Prognostic Indicators For Patients With Distal Cholangiocarcinoma After Radical Surgical Resection. The Second Part Is The Preoperative Platelet-lymphocyte Ratio As An Independent Prognostic Factor For Patients With A
11. The First Part Is The Clinical Characteristics And Prognosis Analysis Of Patients With Primary Myelofibrosis In Different Age Groups. The Second Part Is A Report Of A Case Of Rucotinib In The Treatment Of Chronic Neutrophil Leukemia
12. Economic, environmental, and endowment effects on childhood obesity and school performance
13. The First Part Is The Study Of Proteomics For The Differential Diagnosis Of Ovarian Endometriosis. The Second Part Is The Establishment And Validation Of The Prognosis Prediction Model Of Ovarian Clear Cell Carcinoma
14. The First Part Is To Study The Protective Mechanism Of Ghrelin On Acetic Acid-induced Gastric Injury In Rats. The Second Part Is To Evaluate The Pharmacodynamics Of Gastroprotective Drugs
15. The First Part Of The Whole Genome Analysis To Identify The Hepatitis C Virus Recombination Events And Positive Selection Sites In Mainland China From 2010 To 2019. The Second Part Of The SV40 Virus T Antigen Gene To Produce Circular RNA Mechanism Researc
  <<First  <Prev  Next>  Last>>  Jump to